DAPI

1
DAPI Flag-FOXO3a Merged WT MEFs Untreated Doxorubicin (16h) Untreated Doxorubicin (16h) p38α -/- MEFs Supplementary Figure S7. The transfected Flag-FOXO3a accumulates in the nuclei of the wild-type but not p38α-deficent MEFs following doxorubicin treatment Wild-type and p38α-deficent MEFs were seeded into slide chamber, transfected with the pCMV-Flag-FOXO3a (WT) and incubated with media in the absence or presence of doxorubicin for 16 h. Immunofluorescent staining was then performed using the Flag antibodies and DAPI. All images shown are typical results obtained from at least 10 different fields.

description

Flag-FOXO3a. DAPI. Merged. Untreated. WT MEFs. Doxorubicin (16h ). Untreated. p38α -/- MEFs. Doxorubicin (16h). Supplementary Figure S7. The transfected Flag-FOXO3a accumulates in the nuclei of the wild-type but not p38α-deficent MEFs following doxorubicin treatment - PowerPoint PPT Presentation

Transcript of DAPI

Page 1: DAPI

DAPIFlag-FOXO3a Merged

WT

MEF

s

Untreated

Doxorubicin (16h)

Untreated

Doxorubicin (16h)

p38α

-/- M

EFs

Supplementary Figure S7. The transfected Flag-FOXO3a accumulates in the nuclei of the wild-type but not p38α-deficent MEFs following doxorubicin treatmentWild-type and p38α-deficent MEFs were seeded into slide chamber, transfected with the pCMV-Flag-FOXO3a (WT) and incubated with media in the absence or presence of doxorubicin for 16 h. Immunofluorescent staining was then performed using the Flag antibodies and DAPI. All images shown are typical results obtained from at least 10 different fields.